Search Results - growth

6 Results Sort By:
Mobile Instrumentation for the Detection and Sampling of Aerosol Particles
Hazardous airborne particles pose a risk for health and safety in a variety of environments and thus detection of these small particles is essential. Current particle magnification systems are bulky and require a lot of power for operation, making them unsuitable to easily detect and analyze small particles in mobile and personal settings. CDC/NIOSH...
Published: 10/28/2024   |   Inventor(s): Gregory Deye, Pramod Kulkarni
Keywords(s): AEROSOL, APPLICATIONS, EXCHANGE, Growth, MEMBRANES, NIOSH-DART, PARTICLE, PERSONAL, Proton, Sampling, SYSTEMS, VBXXXX, VEXXXX, WAXXXX, WCXXXX, WGXXXX, WIXXXX, XDXXXX, XIXXXX, YFXXXX
Category(s): Collaboration Sought > Licensing, Application > Therapeutics, Application > Non-Medical Devices, Application > Medical Devices, TherapeuticArea > Neurology, Application > Research Materials, Application > Diagnostics, Application > Vaccines, Application > Occupational Safety and Health
Derivatives of Docosahexaenoylethanolamide (DEA) for Neurogenesis
The invention pertains to derivatives of docosahexaenoylethanolamide (synaptamide or DEA) and their use in inducing neurogenesis, neurite growth, and/or synaptogenesis. As such, these DEA derivatives can be used as therapeutics for neurodegenerative diseases such as traumatic brain injury, spinal cord injury, peripheral nerve injury, stroke, multiple...
Published: 10/28/2024   |   Inventor(s): Erika Englund, Juan Marugan, Samarjit Patnaik, Hee-Yong Kim
Keywords(s): Derivatives, Development, Discovery, Docosahexaenoylamide, Growth, IB6XXX, IBXXXX, IXXXXX, Listed LPM Vepa as of 4/15/2015, NB1FXX, NB1HXX, NB1XXX, NBXXXX, Neurons, NXXXXX, Post LPM Assignment Set 20150420, Pre LPM working set 20150418, Promote, That, VEXXXX, YAXXXX, YBXXXX, YFXXXX
Category(s): Collaboration Sought > Licensing, TherapeuticArea > Neurology, Application > Diagnostics, TherapeuticArea > Reproductive Health, Application > Research Materials, Application > Vaccines, Application > Therapeutics
Fgfr4 Knockout Mouse Model for Respiratory System Studies
FGFR4 knockout: Lung alveoli fail to develop normally in double mutant with FGFR4 and FGFR3 knockouts. The fibroblast growth factor receptor 4 (fgfr-4) gene was inactivated by targeted disruption and homozygous recombination to study its possible role in lung development. FGFR-4 is expressed in postnatal lung, and FGFR-4 null mice have no obvious abnormalities....
Published: 4/8/2024   |   Inventor(s): Chuxia Deng
Keywords(s): 4, factor, FGFR4, Fibroblast, Generation, Growth, IDXXXX, IXXXXX, Knockout, Mice, RECEPTOR
Category(s): Collaboration Sought > Licensing, Application > Diagnostics, Application > Research Materials, Application > Therapeutics
Fibroblast Growth Factor Receptor 1 (Fgfr1) Conditional Knock Out Mouse
Scientists at NIDDK have developed a fibroblast growth factor receptor 1 (Fgfr1) conditional knock out mouse. Fgfr1 is a member of the Fgfr family of transmembrane protein receptors with intrinsic tyrosine kinase activity. Fgfr1 is important in multiple biological processes, including mesoderm induction and patterning, cell growth and migration, organ...
Published: 10/28/2024   |   Inventor(s): Chuxia Deng
Keywords(s): 1, AC5XXX, ACXXXX, AXXXXX, Conditional, factor, FGFR1, Fibroblast, Growth, Knockout, Mice, RECEPTOR
Category(s): Collaboration Sought > Licensing
MDCK Cells with Enhanced Characteristics for Vaccine and Virus Production
This technology relates to compositions and methods for improving the growth characteristics of cells engineered to produce live viruses such as the Influenza virus. Featured is a method that uses the gene candidate, siat7e, or its expressed or inhibited products in Madin Darby Canine Kidney (MDCK) cells. The gene expression modulates anchorage-dependence...
Published: 10/28/2024   |   Inventor(s): Chia Chu, Joseph Shiloach
Keywords(s): Anchorage-independent, CAPABILITY, Cells, DB4XXX, DBXXXX, DC5BXX, DC5XXX, DC6XXX, DCXXXX, DDXXXX, DEXXXX, DXXXXX, EXHIBIT, Gene, Growth, Human, Inserts, MDCK, Patent Category - Biotechnology, Siat7e
Category(s): Collaboration Sought > Collaboration, Collaboration Sought > Licensing, Application > Research Materials, Application > Vaccines, Application > Therapeutics, TherapeuticArea > Infectious Disease
Treatment for Muscle Atrophy and for Enhancing Muscle Growth
An mRNA based therapeutic that provides for increased hepatic production of follistatin Background Muscle atrophy is a detrimental and often severely debilitating disease state whose etiology lies within a myriad of disease states ranging from AIDS, sepsis, cardiac failure, muscular dystrophies, cancer, and the natural process of aging. The extent...
Published: 6/10/2024   |   Inventor(s): Oleh Taratula, Canan Schumann, Olena Taratula, Adam Alani
Keywords(s): atrophy, growth, mRNA carrier, mRNA delivery, muscle, Muscular Dystrophy, wasting
Category(s): Therapeutics